Rhythm Pharmaceuticals CEO exercises RSUs, withholds shares
Rhythm Pharmaceuticals President and CEO David P. Meeker reported the vesting and conversion of restricted stock units into common stock on February 1, 2026.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Rhythm Pharmaceuticals President and CEO David P. Meeker reported the vesting and conversion of restricted stock units into common stock on February 1, 2026. A total of 68,713 restricted stock units were exercised into common shares, and 31,522 shares were withheld at $108.99 per share to satisfy tax obligations. Following these transactions, Meeker directly holds 239,016 shares of common stock and 156,637 restricted stock units.
Insider Trade Summary
68,713 shares exercised/converted
Exercise
5 txns
Insider
Meeker David P
Role
President and CEO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 14,125 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units | 21,250 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units | 33,338 | $0.00 | $0.00 |
| Exercise | Common Stock | 68,713 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 31,522 | $108.99 | $3.44M |
Holdings After Transaction:
Restricted Stock Units — 156,637 contracts (Direct);
Common Stock — 239,016 shares (Direct)
Footnotes (5)
- F1. Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- F2. These shares were withheld for payment of the withholding taxes upon the vesting of the restricted stock units reported herein.
- F3. The restricted stock units vest as to 25% of the total shares on each of February 1, 2024, February 1, 2025, February 1, 2026 and February 1, 2027. The restricted stock units have no expiration date.
- F4. The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 1, 2026, February 1, 2027 and February 1, 2028. The restricted stock units have no expiration date.
- F5. The restricted stock units vest as to 25% of the total shares on each of February 1, 2026, February 1, 2027, February 1, 2028 and February 1, 2029. The restricted stock units have no expiration date.
Key Figures
RSUs exercised: 68,713 shares
Shares withheld for taxes: 31,522 shares
Tax withholding price: $108.99 per share
+2 more
5 metrics
RSUs exercised
68,713 shares
Restricted stock units converted into common stock on February 1, 2026
Shares withheld for taxes
31,522 shares
Common shares delivered at $108.99 per share to cover withholding taxes
Tax withholding price
$108.99 per share
Per-share value used for the tax-withholding disposition of common stock
Post-transaction common stock holdings
239,016 shares
Direct common stock owned by David P. Meeker after the reported transactions
Post-transaction RSU holdings
156,637 units
Direct restricted stock units held by David P. Meeker after vesting events
Key Terms
Restricted Stock Units, tax-withholding disposition, derivative security, contingent right
4 terms
Restricted Stock Units financial
"Each restricted stock unit represents a contingent right to receive one share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax-withholding disposition financial
"Payment of exercise price or tax liability by delivering securities"
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
derivative security financial
"Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
contingent right financial
"represents a contingent right to receive one share of Issuer common stock"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider activity did RYTM's CEO report in this Form 4?
David P. Meeker reported the vesting and conversion of 68,713 restricted stock units into common stock on February 1, 2026, with 31,522 shares withheld at $108.99 per share to cover tax obligations.
What are David Meeker's post-transaction common stock holdings in RYTM?
After the reported transactions, David P. Meeker directly owns 239,016 shares of Rhythm Pharmaceuticals common stock, according to the canonical post-transaction holdings data.
How many restricted stock units does RYTM's CEO still hold after these transactions?
Following the February 1, 2026 vesting events, David P. Meeker continues to hold 156,637 restricted stock units, representing additional contingent rights to receive Rhythm Pharmaceuticals common shares.
What does each restricted stock unit in RYTM represent for the CEO?
Each restricted stock unit represents a contingent right to receive one share of Rhythm Pharmaceuticals common stock, with vesting over specified dates as described in the filing footnotes.
AI-generated analysis. How Rhea-AI works. Not financial advice.
